Company: INDP
Filing Date: 2025-01-14
Form Type: 8-K
Source: 0001493152-25-002145
Chunk: 1

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-01-14
Form: 8-K
Item: Item 1.01
Chunk 1
---
efforts to keep such registration statement effective at all times until the earlier of (i) the date that no Purchaser owns any Warrants
or Warrant Shares issuable upon exercise thereof and (ii) the two year anniversary of the closing date.

The
foregoing descriptions of the Purchase Agreements and the Warrants are not complete and are qualified in its entirety by reference to
the full text of the Purchase Agreements and the Warrants, a form of each of which are filed as Exhibits 10.1 and 10.2 to this Current
Report on Form 8-K (“ Form 8-K”) and are incorporated by reference herein.

Paulson
Investment Company, LLC (“ Paulson”) served as the exclusive placement agent for the issuance and sale of securities of the
Company pursuant to a Placement Agency Agreement (the “ PAA”) between the Company and Paulson. As compensation for such placement
agent services, the Company has agreed to pay Paulson an aggregate cash fee equal to 7.0% of the gross proceeds received by the Company
from the offering, and a non-accountable expense of $25,000. In addition, Paulson is entitled to certain tail rights for a period of
one year following the termination or expiration of the PAA. As additional compensation to Paulson, the Company issued to the Placement
Agent (or its designees) a warrant (the “ Placement Agent Warrants”) to purchase an aggregate of up to 147,656 shares
of Common Stock (the “ Placement Agent Warrant Shares”) at an exercise price per share equal to $1.175. The Placement Agent
Warrants are exercisable six months from the date of issuance and expires on the fifth anniversary of the issue date. The PAA contains
certain customary representations and warranties and indemnification obligations of the Company and Paulson.

The
foregoing description of the PAA and Placement Agent Warrants are not complete and are qualified in their entirety by reference to the
full text of the PAA and the form of Placement Agent Warrant, which are filed as Exhibits 10.3 and 10.4 to this Form 8-K, respectively,
and are incorporated by reference herein.

This
Form 8-K shall not constitute an offer to sell or the solicitation of any offer to buy the securities discussed herein, nor shall there
be any offer, solicitation or sale of the securities in any state in which such offer, solicitation or sale would be unlawful